Professional Documents
Culture Documents
disease, and different kinds of dementia, a holistic approach to symptom treatment and quality of
life is needed. There are both pharmacological and non-pharmacological treatments available to
address the diverse requirements of those affected by these illnesses. Medications are frequently
a key component of therapy, with specialized treatments designed to manage cognitive decline.
Cholinesterase inhibitors such as donepezil, rivastigmine, and galantamine are commonly used to
improve cognitive performance and decrease the course of Alzheimer's disease symptoms.
Moreover, Memantine can also be used, especially for moderate to severe symptoms. Similarly,
with Parkinson's disease dementia, drugs that target dopamine levels, such as levodopa-
carbidopa, can help with both cognitive and motor symptoms. Aside from medication, many
therapeutic approaches play important roles in holistic care (Szeto & Lewis, 2016).
Holistic treatment is essential for meeting the various requirements of people with
emotional support to patients and their families as they manage the obstacles of chronic
cognitively stimulating activities like puzzles, reading, and social interactions, are critical
The main objective of caring for neurocognitive diseases is to improve the quality of life
via compassion and understanding. This entails creating a supportive atmosphere that values the
dignity and autonomy of those impacted by such situations. Caregivers play an important role in
adopting person-centred care strategies that prioritize the individual's preferences, strengths, and
values. Developing a regular schedule, giving sensory stimulation, and implementing safety
precautions can all help patients and caregivers feel more secure and stable. Individuals with
neurocognitive disorders can promote dignity, autonomy, and general well-being by addressing
their various needs via comprehensive care techniques and treatment alternatives.
References
Szeto, J. Y., & Lewis, S. J. (2016). Current Treatment Options for Alzheimer's Disease and
https://doi.org/10.2174/1570159x14666151208112754